Iryo

by Iryo

(0)
View Profile

FarmaTrust

by FarmaTrust

(0)
View Profile

DOC.com

by DOC.com

(0)
View Profile

Iryo

by Iryo

(0)
View Profile

FarmaTrust

by FarmaTrust

(0)
View Profile

DOC.com

by DOC.com

(0)
View Profile

What problem does this service solve?

Iryo is developing a unified blockchain platform for tracking healthcare records.FarmaTrust uses blockchain to help consumers and healthcare professionals track the supply chains of medications.DOC.com's telemedicine platform uses blockchain and AI to increase access to healthcare.

Token Stats

Not Relevant

Company Description

Iryo's goal is to create a tokenized platform for tracking healthcare records. Iryo’s solution is meant to store data securely and allow patients to share their medical history anywhere in the world. Iryo is conducting a pilot program in Slovenia at the moment, and is also partnering with aid organizations to assist in the healthcare operations of refugees in the Middle East. The Iryo Token is designed as a gateway cryptocurrency that will enable patients and healthcare professionals to participate in Iryo’s global healthcare network. The token will encourage collaboration and promote medical research.

FarmaTrust is developing a supply chain tracking system for the pharmaceutical industry. FarmaTrust is working to partner with pharmaceutical companies, distributors, regulators, and other stake holders to set up a decentralized platform that will allow consumers to track their medications along the entire supply chain. Their network will be powered by the Ethereum-based FTT token.

DOC.com is a blockchain enabled Telemedicine platform. Their goal is to use AI and blockchain to provide greater access to healthcare. Anyone with a cell phone can use their network to get diagnosed, treated, or referred to a medical specialist. They are also developing AI-based educational tools for medical professionals. Doc.com will use a blockchain to record and manage healthcare data, and will use the Ethereum-based MTC token to power their network.

Ratings

(0)

(0)

(0)